These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11213894)

  • 21. Different risk factors for cognitive impairment among community-dwelling elderly, with impaired fasting glucose or diabetes.
    Xiu S; Zheng Z; Liao Q; Chan P
    Diabetes Metab Syndr Obes; 2019; 12():121-130. PubMed ID: 30666140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive status and incident disability in older Mexican Americans: findings from the Hispanic established population for the epidemiological study of the elderly.
    Raji MA; Al Snih S; Ray LA; Patel KV; Markides KS
    Ethn Dis; 2004; 14(1):26-31. PubMed ID: 15002920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project.
    Guo Z; Fratiglioni L; Winblad B; Viitanen M
    Am J Epidemiol; 1997 Jun; 145(12):1106-13. PubMed ID: 9199540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
    Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
    Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship Between Fasting Blood Glucose Levels in Middle Age and Cognitive Function in Later Life: The Aichi Workers' Cohort Study.
    Shimoda M; Kaneko K; Nakagawa T; Kawano N; Otsuka R; Ota A; Naito H; Matsunaga M; Ichino N; Yamada H; Chiang C; Hirakawa Y; Tamakoshi K; Aoyama A; Yatsuya H
    J Epidemiol; 2023 Feb; 33(2):76-81. PubMed ID: 34024876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
    Tominaga M; Eguchi H; Manaka H; Igarashi K; Kato T; Sekikawa A
    Diabetes Care; 1999 Jun; 22(6):920-4. PubMed ID: 10372242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.
    Abbatecola AM; Rizzo MR; Barbieri M; Grella R; Arciello A; Laieta MT; Acampora R; Passariello N; Cacciapuoti F; Paolisso G
    Neurology; 2006 Jul; 67(2):235-40. PubMed ID: 16864814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognition in non-demented diabetic older adults.
    Nandipati S; Luo X; Schimming C; Grossman HT; Sano M
    Curr Aging Sci; 2012 Jul; 5(2):131-5. PubMed ID: 22023096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-associated cognitive decline in healthy old people.
    Starr JM; Deary IJ; Inch S; Cross S; MacLennan WJ
    Age Ageing; 1997 Jul; 26(4):295-300. PubMed ID: 9271293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
    Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
    Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired attention predicts motor performance decline in older community-dwellers with normal baseline mobility: results from the Italian Longitudinal Study on Aging (ILSA).
    Inzitari M; Baldereschi M; Di Carlo A; Di Bari M; Marchionni N; Scafato E; Farchi G; Inzitari D;
    J Gerontol A Biol Sci Med Sci; 2007 Aug; 62(8):837-43. PubMed ID: 17702874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial.
    Umegaki H; Iimuro S; Shinozaki T; Araki A; Sakurai T; Iijima K; Ohashi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():103-9. PubMed ID: 22435945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey.
    Lindeman RD; Romero LJ; LaRue A; Yau CL; Schade DS; Koehler KM; Baumgartner RN; Garry PJ;
    Diabetes Care; 2001 Sep; 24(9):1567-72. PubMed ID: 11522700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between blood pressure, cognitive function and education level in elderly patients with diabetes: a preliminary study.
    Talfournier J; Bitu J; Paquet C; Gobron C; Guillausseau PJ; Hugon J; Dumurgier J
    Diabetes Metab; 2013 Oct; 39(5):418-23. PubMed ID: 23643352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
    Verdelho A; Madureira S; Ferro JM; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1325-30. PubMed ID: 17470472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoglycemia and cognitive function in diabetic patients.
    Ebadi SA; Darvish P; Fard AJ; Lima BS; Ahangar OG
    Diabetes Metab Syndr; 2018 Nov; 12(6):893-896. PubMed ID: 29887517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood pressure and related cognition among elderly residents in the community in Beijing - a 4-year longitudinal study].
    Zhang YC; Tang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):833-6. PubMed ID: 15631733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing Mini-Mental State Examination and Attention and Digit Span in elderly exposed to polychlorinated biphenyls and polychlorinated dibenzofurans.
    Lin KC; Huang PC; Yeh PS; Kuo JR; Ke DS
    Psychogeriatrics; 2010 Dec; 10(4):191-7. PubMed ID: 21159054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study.
    Elias PK; Elias MF; D'Agostino RB; Cupples LA; Wilson PW; Silbershatz H; Wolf PA
    Diabetes Care; 1997 Sep; 20(9):1388-95. PubMed ID: 9283785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study.
    Paterniti S; Dufouil C; Alpérovitch A
    J Clin Psychopharmacol; 2002 Jun; 22(3):285-93. PubMed ID: 12006899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.